Actinium Pharmaceuticals Inc (ATNM)
6.55
-0.51
(-7.22%)
USD |
NYAM |
Apr 25, 16:00
6.55
0.00 (0.00%)
After-Hours: 20:00
Actinium Pharmaceuticals Cash from Operations (Quarterly): -7.49M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -7.49M |
| September 30, 2023 | -11.12M |
| June 30, 2023 | -13.64M |
| March 31, 2023 | -15.08M |
| December 31, 2022 | -7.778M |
| September 30, 2022 | -5.715M |
| June 30, 2022 | 27.92M |
| March 31, 2022 | -5.781M |
| December 31, 2021 | -5.052M |
| September 30, 2021 | -5.588M |
| June 30, 2021 | -4.584M |
| March 31, 2021 | -5.642M |
| December 31, 2020 | -6.258M |
| September 30, 2020 | -4.994M |
| June 30, 2020 | -4.511M |
| March 31, 2020 | -5.854M |
| December 31, 2019 | -5.011M |
| September 30, 2019 | -5.598M |
| June 30, 2019 | -5.364M |
| March 31, 2019 | -5.489M |
| December 31, 2018 | -4.287M |
| September 30, 2018 | -6.614M |
| June 30, 2018 | -4.211M |
| March 31, 2018 | -5.459M |
| December 31, 2017 | -3.168M |
| Date | Value |
|---|---|
| September 30, 2017 | -5.87M |
| June 30, 2017 | -7.140M |
| March 31, 2017 | -5.375M |
| December 31, 2016 | -4.241M |
| September 30, 2016 | -5.570M |
| June 30, 2016 | -6.222M |
| March 31, 2016 | -4.756M |
| December 31, 2015 | -3.964M |
| September 30, 2015 | -3.499M |
| June 30, 2015 | -5.267M |
| March 31, 2015 | -5.813M |
| December 31, 2014 | -5.047M |
| September 30, 2014 | -4.239M |
| June 30, 2014 | -2.571M |
| March 31, 2014 | -2.491M |
| December 31, 2013 | -1.344M |
| September 30, 2013 | -1.620M |
| June 30, 2013 | -1.016M |
| March 31, 2013 | -2.312M |
| December 31, 2012 | -1.417M |
| September 30, 2012 | -1.933M |
| June 30, 2012 | -0.9143M |
| March 31, 2012 | -0.9479M |
| December 31, 2011 | -0.5225M |
| September 30, 2011 | 0.00 |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-15.08M
Minimum
Mar 2023
27.92M
Maximum
Jun 2022
-5.113M
Average
-5.642M
Median
Mar 2021
Cash from Operations (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -9.008M |
| Eli Lilly and Co | -311.90M |
| Cellectar Biosciences Inc | -9.596M |
| Bristol-Myers Squibb Co | 4.252B |
| Oragenics Inc | -1.102M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Financing (Quarterly) | 1.192M |
| Free Cash Flow | -47.49M |
| Free Cash Flow Per Share (Quarterly) | -0.2731 |
| Free Cash Flow to Equity (Quarterly) | -7.49M |
| Free Cash Flow Yield | -27.26% |